Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study

Title

Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study

Identifier

/unibl/sci/idNaucniRad:35094
info:doi/doi.org/10.1007/s00210-024-03136-1

Type

See all items with this valueAcademic Article
See all items with this valuetext

Date

See all items with this value2024-05

Bibliographic Citation

P. Kovačević, D. Milaković, T. Kovačević, V. Barišić, S. Dragić, B. Zlojutro, B. Miljković, K. Vučićević, Z. Rizwan, Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study, NAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY, Vol. 397, pp. 7747 - 7756, May, 2024

References

https://link.springer.com/article/10.1007/s00210-024-03136-1#Abs1

page start

7747

page end

7756

Is Part Of

See all items with this valueNAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY
See all items with this value0028-1298

list of authors

See all items with this valuePeđa Kovačević
See all items with this valueDragana Milaković
See all items with this valueTijana Kovačević
See all items with this valueVedrana Barišić
See all items with this valueSaša Dragić
See all items with this valueBiljana Zlojutro
See all items with this valueBranislava Miljković
See all items with this valueKatarina Vučićević
See all items with this valueZeeshan Rizwan

Position: 133639 (9 views)